Services

Toxicology

Pharmacology

Animal Model Development

Medical Device Testing

In Vitro Screening

Custom Assay Development

Vivarium Rental

Histology

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Species

Non-human Primates

Dogs

Minipigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Careers

Request a Quote

Logo
☰
  • Services ⌄
    • Toxicology
    • Pharmacology
    • Animal Model Development
    • Medical Device Testing
    • In Vitro Screening
    • Custom Assay Development
    • Vivarium Rental
    • Histology
  • Therapeutic Areas ⌄
    • Oncology
    • Immunology & Inflammation
    • Neurology / CNS
    • Cardiovascular
    • Dermatology & Wound Healing
    • Metabolism
    • Gastroenterology
    • Hepatology
    • Pulmonology
    • Infectious Diseases & Sepsis
    • Musculoskeletal
    • Nephrology & Urology
  • Species ⌄
    • Non-human Primates
    • Dogs
    • Minipigs / Pigs
    • Rabbits
    • Mice
    • Rats
    • Sheep
    • Guinea Pigs
    • Hamsters
    • Other Species
  • Capabilities ⌄
    • GLP / IND-Enabling Studies
    • Small and Large Animal Housing
    • Bioanalytical Platforms
  • About ⌄
    • News
  • Contact ⌄
    • Careers
    • Request a Quote

EU Issues Track-and-Trace Packaging Safety Rules to Take Effect in 2019

  • Post author:Sam
  • Post published:March 17, 2016
  • Post category:International Pharmaceutical Regulatory Monitor

The European Medicines Agency and the European Commission published new track-and-trace safety requirements Feb. 10 affecting all drugmakers doing business in EU countries. Source: International Pharmaceutical Regulatory Monitor

Continue ReadingEU Issues Track-and-Trace Packaging Safety Rules to Take Effect in 2019

EMA Proposes Revisions to Module V of GVPs on Risk Management Systems

  • Post author:Sam
  • Post published:March 17, 2016
  • Post category:International Pharmaceutical Regulatory Monitor

The European Medicines Agency has begun a public consultation on planned revisions to Module V of the good pharmacovigilance practices on risk management systems, which clarifies what risk management plans…

Continue ReadingEMA Proposes Revisions to Module V of GVPs on Risk Management Systems

Celltrion’s Remicade Biosimilar Gets Adcomm Backing for 6 Indications

  • Post author:Sam
  • Post published:March 17, 2016
  • Post category:International Pharmaceutical Regulatory Monitor

An FDA advisory committee gave South Korea’s Celltrion’s biosimilar candidate for Remicade a strong show of support Feb. 9, backing its approval for six indications. Source: International Pharmaceutical Regulatory Monitor

Continue ReadingCelltrion’s Remicade Biosimilar Gets Adcomm Backing for 6 Indications

France’s ANSM Dings Chinese Drugmaker Over 10 GMP Concerns Cited at Plant

  • Post author:Sam
  • Post published:March 17, 2016
  • Post category:International Pharmaceutical Regulatory Monitor

Heparin is back in the news, after France’s National Agency for Medicines and Health Products Safety issued a GMP noncompliance statement to China’s Dongying Tiandong Pharmaceutical, which manufactures the active…

Continue ReadingFrance’s ANSM Dings Chinese Drugmaker Over 10 GMP Concerns Cited at Plant

Mylan Announces Intentions to Buy Sweden’s Meda for $7.2B

  • Post author:Sam
  • Post published:March 17, 2016
  • Post category:International Pharmaceutical Regulatory Monitor

Generics giant Mylan N.V. has struck a tentative deal to purchase Swedish drugmaker Meda AB for $7.2 billion in cash and stock. Source: International Pharmaceutical Regulatory Monitor

Continue ReadingMylan Announces Intentions to Buy Sweden’s Meda for $7.2B

EMA Issues Positive Recommendations for 6 Drugs to European Commission

  • Post author:Sam
  • Post published:March 17, 2016
  • Post category:International Pharmaceutical Regulatory Monitor

Six new drugs have scored wins at the European Medicines Agency, scooping up recommendations for marketing authorization from the Committee for Medicinal Products for Human Use. Source: International Pharmaceutical Regulatory…

Continue ReadingEMA Issues Positive Recommendations for 6 Drugs to European Commission

Trade Deal Signing Sets the Stage for New Biologics Exclusivity Policy

  • Post author:Sam
  • Post published:March 17, 2016
  • Post category:International Pharmaceutical Regulatory Monitor

With 12 nations signing off on the Trans-Pacific Partnership, the clock has started on ratification of the treaty providing up to eight years of exclusivity for biologics. Source: International Pharmaceutical…

Continue ReadingTrade Deal Signing Sets the Stage for New Biologics Exclusivity Policy

NHS England Plans to Investigate Alleged Staff Ties to Drugmakers

  • Post author:Sam
  • Post published:March 17, 2016
  • Post category:International Pharmaceutical Regulatory Monitor

An NHS England spokesperson confirmed Feb. 18 that the agency will investigate whether more than 130 NHS staff involved in assessing drugs were also paid as consultants by drugmakers. Source:…

Continue ReadingNHS England Plans to Investigate Alleged Staff Ties to Drugmakers

EMA Spells Out Disclosure Policy for Clinical Data Set for Publication

  • Post author:Sam
  • Post published:March 17, 2016
  • Post category:International Pharmaceutical Regulatory Monitor

Drugmakers submitting anonymized clinical data in applications to the EMA must keep up on technology advances that could put that data at risk for re-identification. Source: International Pharmaceutical Regulatory Monitor

Continue ReadingEMA Spells Out Disclosure Policy for Clinical Data Set for Publication

Warning Letter Hits India’s Ipca Labs on Allegations of Data Manipulation

  • Post author:Sam
  • Post published:March 17, 2016
  • Post category:International Pharmaceutical Regulatory Monitor

The FDA has slammed yet another Indian drugmaker for data integrity issues. This time it rebuked Ipca Laboratories for data falsification at three of the company’s manufacturing facilities. Source: International…

Continue ReadingWarning Letter Hits India’s Ipca Labs on Allegations of Data Manipulation
  • 1
  • 2
  • 3
  • 4
  • Go to the next page

Stay Connected

Keep up with the latest news & insights.

Contact Us

Phone:
+1 858-605-5882
Fax:
+1 858-605-5916
Email:
info@biolegacyresearch.com
Mail:
6042 Cornerstone Court W
Suite E
San Diego, CA 92121
Social::
© 2025 BioLegacy Research. All rights reserved.
BioLegacy research is a PharmaLegacy Laboratories company